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The phosphatidylethanolamine derivative 1,2-O-bis-[8-{2-(2-pentyl-cyclopropylmethyl)-cyclopropyl}-
octanoyl]-sn-glycero-3-phosphatidylethanolamine (diDCP-LA-PE) promoted GLUT4 translocation to the
cell surface in differentiated 3T3-L1-GLUT4myc adipocytes through a pathway along a phosphatidyli-
nositol 3-kinase (PI3K)/3-phosphoinositide-dependent protein kinase-1 (PDK1)/Akt axis, that mimics
insulin signaling. Moreover, diDCP-LA-PE-induced GLUT4 translocation was suppressed by inhibitors of
the Rho GTPase Rac1 and Rho-associated coiled-coil-containing protein kinase (ROCK) or knocking-down
Rac1 and ROCK1. The results of the present study show that Rac1 and ROCK are critical for regulation of
GLUT4 trafﬁcking by diDCP-LA-PE as well as insulin.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Insulin promotes GLUT4-mediated glucose uptake into skeletal
muscle cells and adipocytes through a pathway along an insulin
receptor (IR)/IR substrate 1 (IRS-1)/PI3K/PDK1/Akt axis (1). Insulin
is shown to activate a variety of PKC isozymes including PKCa, -bІІ,
-d, -l/i and -z (2e5), and of them PKCl/i and -z stimulate GLUT4
translocation to the cell surface, regardless of the pathway
described above (6e8). In addition, PKCεmay also participate in the
regulation of GLUT4 trafﬁcking (9). Accumulating evidence has
pointed to the implication of Rho GTPases such as RhoA, Rac1,
Cdc42 and TC10 in insulin-regulated GLUT4 trafﬁcking (10, 11). The
RhoA effector ROCK, alternatively, plays a role in the regulation of
insulin-stimulated GLUT4-mediated glucose uptake (12, 13).
We have earlier found that the phosphatidylethanolamine de-
rivative diDCP-LA-PE, whichwehave originally synthesized, has the
potential to inhibit PTP1B and activate a variety of PKC isozymes
(14). PTP1B inhibition could enhance an IR/IRS-1/PI3K/PDK1/Aktizaki).
rmacological Society.
g by Elsevier B.V. on behalf of Japa
d/4.0/).signaling pathway due to inhibition of tyrosine dephosphorylation
of IR and IRS-1. Notably, diDCP-LA-PE activated the novel PKC iso-
zymes PKCz and PKCl/i, although such effect was not obtained with
the other phospholipid derivatives 1,2-O-bis-[8-{2-(2-pentyl-
cyclopropylmethyl)-cyclopropyl}-octanoyl]-sn-glycero-3-phospha
tidyl-L-serine (diDCP-LA-PS), 1,2-O-bis-[8-{2-(2-pentyl-cyclopropyl
methyl)-cyclopropyl}-octanoyl]-sn-glycero-3-phosphatidylcholine
(diDCP-LA-PC), or 1,2-O-bis-[8-{2-(2-pentyl-cyclopropylmethyl)-
cyclopropyl}-octanoyl]-sn-glycero-3-phosphatidyl-D-1-inositol (di
DCP-LA-PI) (14). Then,we postulated that diDCP-LA-PE couldmimic
intracellular insulin signaling.
To address this hypothesis, the present study investigated
diDCP-LA-PE-induced GLUT4 translocation in differentiated 3T3-
L1-GLUT4myc adipocytes and the underlying mechanism. We
show here that diDCP-LA-PE as well as insulin stimulates GLUT4
translocation to the cell surface through a PI3K/PDK1/Akt pathway
and that Rac1 and ROCK also participate in the regulation of the
GLUT4 trafﬁcking.nese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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2.1. Cell culture
3T3-L1-GLUT4myc ﬁbroblast cell line, expressing GLUT4myc
that is constructed by inserting a human c-MYC epitope (14 amino
acids) into the ﬁrst ectodomain of GLUT4. Cells were cultured by the
method as described previously (1). We have conﬁrmed in the Oil-
Red O staining and Western blot analysis using an anti-peroxisome
proliferator-activated receptor g antibody that cells used here are
well differentiated into adipocytes.2.2. Monitoring of GLUT4 trafﬁcking
Differentiated 3T3-L1-GLUT4myc adipocytes were separated
into the cytosolic and plasmamembrane fractions by themethod as
previously described (1), and GLUT4 in each fractionwas quantiﬁed
in the Western blot analysis by detecting the exofacial MYC tagFig. 1. Insulin and diDCP-LA-PE promotes GLUT4 translocation towards the cell surface thr
adipocytes treated with insulin (100 nM) or diDCP-LA-PE (1 mM) in the presence and absenc
or MK2206 (MK) (5 mM) (D) for 20 min. C, cytosol fraction; M, plasma membrane fraction. In
plasma membrane relative to that for whole cells (n ¼ 4 independent experiments). P valuusing an anti-mouse c-myc antibody (1:10000 dilution) (Merck
Millipore, Darmstadt, Germany).2.3. Construction and transfection of siRNA
The siRNAs to silence the PI3 kinase p85a (PI3K)-, PDK1-, Akt1/
2-, Rac1-, or ROCK1-targeted gene and the negative control (NC)
siRNA were obtained from Santa Cruz Biotechnology (Santa Cruz,
CA, USA) or Ambion (Carlsbad, CA, USA). siRNAs (50 pmol/dish)
were transfected into differentiated 3T3-L1-GLUT4myc adipocytes
using a Lipofectamine reagent (Invitrogen, Carlsbad, CA, USA), and
cells were used for experiments 48 h after transfection.2.4. Inhibitors
Inhibitors used here are genistein (Nacalai Tesque, Kyoto, Japan),
wortmannin (Cayman Chemical Company, Ann Arbor, MI, USA),
MK2206 (Selleck Chemicals, Houston, TX, USA), BX912 (Axonough a pathway along an IRS-1/PI3K/PDK1/Akt axis. Differentiated 3T3-L1-GLUT4myc
e of genistein (GS) (50 mM) (A), wortmannin (WM) (1 mM) (B), BX912 (BX) (100 nM) (C)
the graphs, each column represents the mean (±SEM) signal intensity for GLUT4 on the
es, ANOVA followed by a Bonferroni correction. NS, not signiﬁcant.
Fig. 2. Insulin- and diDCP-LA-PE-induced GLUT4 translocation is suppressed by
knocking-down PI3K, PDK1 or Akt1/2. Differentiated 3T3-L1-GLUT4myc adipocytes,
A. Tsuchiya et al. / Journal of Pharmacological Sciences 128 (2015) 179e184 181Medchem, Reston, VA, USA), NSC23766 (Tocris Bioscience, Bristol,
UK), and Y27632 (Merck Millipore, Darmstadt, Germany).
2.5. Western blotting
Western blotting was carried out using an anti-rabbit PI3K
antibody (Sigma, St. Louis, MO, USA), an anti-rabbit PDK1 antibody
(Sigma), an anti-rabbit Akt1/2 antibody (Cell Signaling Technology,
Inc., Danvers, MA, USA), an anti-rabbit Rac1 antibody (Sigma), an
anti-rabbit ROCK1 antibody (Cell Signaling), an anti-mouse b-actin
antibody (Sigma), which are diluted at 1/10000, followed by a
horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG
antibody or anti-rabbit IgG antibody (MP Biomedicals, LLC., Solon,
OH, USA).
2.6. diDCP-LA-PE
diDCP-LA-PE was synthesized in our laboratory by the method
described previously (14). diDCP-LA-PE was dissolved with a
chloroform/dimethyl sulfoxide (DMSO) mixture and diluted with
Krebs-Ringer-HEPES buffer (136 mM NaCl, 4.7 mM KCl, 1.25 mM
CaCl2, 1.25 mM MgSO4 and 20 mM HEPES, pH 7.5) containing 0.2%
(w/v) bovine serum albumin (BSA) supplemented with 10 mM
glucose.
2.7. Statistical analysis
Statistical analysis was carried out using unpaired t-test and
analysis of variance (ANOVA) followed by a Bonferroni correction.
3. Results
Insulin increased cell surface localization of GLUT4 in differen-
tiated 3T3-L1-GLUT4myc adipocytes (Fig. 1AeD). The effect of in-
sulin was abrogated by the tyrosine kinase inhibitor genistein (GS),
the PI3K inhibitor wortmannin (WM), the PDK1 inhibitor BX912
(BX) or the Akt inhibitor MK2206 (MK), although each inhibitor had
no effect on cell surface localization of GLUT4 (Fig. 1AeD). This
indicates that insulin stimulates GLUT4 translocation towards the
cell surface through a pathway along an IR/IRS-1/PI3K/PDK1/Akt
axis. Likewise, diDCP-LA-PE increased cell surface localization of
GLUT4, and the effect was signiﬁcantly inhibited by GS, WM, BX or
MK (Fig. 1AeD). This suggests that diDCP-LA-PE stimulates GLUT4
translocation towards the cell surface through a pathway shared
with insulin signaling.
To obtain further evidence for this notion, PI3K, PDK1 or Akt1/2
was knocked-down using each siRNA. Whether each protein is
successfully knocked-down was conﬁrmed by quantifying each
protein in the Western blot analysis (Fig. 2AeC). Insulin increased
cell surface localization of GLUT4 in cells transfected with the NC
siRNA, and the effect was clearly inhibited by knocking-down PI3K,
PDK1 or Akt1/2 (Fig. 2AeC). This implies that insulin stimulates
GLUT4 delivery to the cell surface in a PI3K-, PDK1- and Akt-
dependent manner. diDCP-LA-PE increased cell surface localiza-
tion of GLUT4 in cells transfected with the NC siRNA, and the effecttransfected with siRNAs for PI3K (A), PDK1 (B) or Akt1/2 (C), were treated with insulin
(100 nM) or diDCP-LA-PE (diDCP) (1 mM) for 20 min. In the graphs in the left panels,
each column represents the mean (±SEM) signal intensity for each protein normalized
by that for b-actin (n ¼ 4 independent experiments). P values, unpaired t-test. In the
graphs in the right panels, each column represents the mean (±SEM) signal intensity
for GLUT4 on the plasma membrane relative to that for whole cells (n ¼ 4 independent
experiments). P values, ANOVA followed by a Bonferroni correction. NS, not signiﬁcant.
Fig. 3. Insulin and diDCP-LA-PE promotes GLUT4 translocation towards the cell surface by targeting Rac1 or ROCK. Differentiated 3T3-L1-GLUT4myc adipocytes treated with insulin
(100 nM) or diDCP-LA-PE (1 mM) in the presence and absence of NSC23766 (NSC) (50 mM) (A) or Y27632 (Y) (10 mM) (B) for 20 min. In the graphs, each column represents the mean
(±SEM) signal intensity for GLUT4 on the plasma membrane relative to that for whole cells (n ¼ 4 independent experiments). P values, ANOVA followed by a Bonferroni correction.
NS, not signiﬁcant.
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(Fig. 2AeC). This accounts for diDCP-LA-PE-induced GLUT4 trans-
location through a PI3K/PDK1/Akt pathway.
Moreover, insulin-induced increase in the cell surface localiza-
tion of GLUT4 was inhibited by the Rac1 inhibitor NSC23766 (NSC),
but not signiﬁcantly (Fig. 3A). diDCP-LA-PE-induced GLUT4 trans-
location was signiﬁcantly inhibited by NSC (Fig. 3A). Expression of
Rac1 in cells transfected with the Rac1 siRNA was signiﬁcantly
decreased as compared with that in cells transfected with the NC
siRNA (Fig. 4A), conﬁrming successful knock-down of Rac1. The
effects of insulin and diDCP-LA-PE on GLUT4 translocation were
signiﬁcantly prevented by knocking-down Rac1 (Fig. 4A). Collec-
tively, these results indicate that Rac1 is implicated in the regula-
tion of insulin- and diDCP-LA-PE-induced GLUT4 translocation.
Notably, insulin- and diDCP-LA-PE-induced increase in the cell
surface localization of GLUT4 was deﬁnitely suppressed by the
ROCK inhibitor Y27632 (Y) (Fig. 3B). In the Western blot analysis,
the signal intensity reactive to an anti-ROCK1 antibody in cells
transfected with the ROCK1 siRNA was obviously reduced as
compared with that in cells transfected with the NC siRNA
(Fig. 4B), indicating successful knock-down of ROCK1. The effects
of insulin and diDCP-LA-PE on GLUT4 translocation were signiﬁ-
cantly prevented by knocking-down ROCK1 (Fig. 4B). Taken
together, these results indicate that ROCK is also implicated in the
regulation of insulin- and diDCP-LA-PE-induced GLUT4
translocation.
4. Discussion
IR is a receptor tyrosine kinase (RTK), and when activated IR
phosphorylates its own receptor and IRS-1 at the tyrosine residue.
Phosphorylated IRS-1 recruits and activates PI3K, to produce
phosphatidylinositol 3,4,5-triphosphate [PI(3,4,5)P3] by phosphor-
ylating phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2]. PI(3,4,5)
P3 binds to and activates PDK1. PI3K and PDK1 activate Akt by
phosphorylating at the serine and threonine residues, whichtriggers GLUT4 translocation towards the cell surface (Fig. 5). PI3K
also activates PKCz, which participates in the regulation of GLUT4
translocation (Fig. 5). The phosphatidylethanolamine derivative
diDCP-LA-PE serves as a potent PTP1B inhibitor and a PKCz acti-
vator (14). diDCP-LA-PE-induced PTP1B inhibition could enhance IR
signaling by preventing tyrosine dephosphorylation of IR and IRS-1.
The PTP1B inhibitor sodium orthovanadate, however, did not affect
GLUT4 translocation, while it enhanced serine phosphorylation of
Akt (unpublished data). This interprets that only PTP1B inhibition
can not activate a PI3K/PDK1/Akt pathway sufﬁciently to trans-
locate GLUT4. diDCP-LA-PE promoted GLUT4 delivery to the plasma
membrane. Collectively, these results suggest that PKCz activation
in addition to PTP1B inhibition may be required for GLUT4 trans-
location. diDCP-LA-PE, thus, appears to stimulate GLUT4 trans-
location towards the cell surface by the mechanisms relevant to
activation of a PI3K/PDK1/Akt pathway in association with PTP1B
inhibition and to direct PKCz activation, in a fashion that mimics
insulin signaling.
The most striking ﬁnding in the present study is that Rac1 and
ROCK are implicated in the regulation of insulin- and diDCP-LA-PE-
induced GLUT4 translocation. In the insulin signaling pathway,
PI3K activates Rac1 by activating the Rac1 guanine nucleotide ex-
change factor (GEF) Tiam1 (15) and activated Rac1 promotes GLUT4
translocation towards the cell surface by remodeling actin ﬁla-
ments (10) (Fig. 5). Interestingly, constitutive activation of
FLJ00068, a Rac1 GEF, enables GLUT4 translocation without insulin
stimulation (16). Taken together, diDCP-LA-PE appears to promote
GLUT4 translocation not only through a pathway along a PI3K/
PDK1/Akt axis but a pathway along PI3K/Rac1 axis still in the
absence of insulin.
Activated Rac1, in turn, binds to and activate the Rac1 effector
Dbs, a RhoA GEF (17). Activated RhoA activates the RhoA effector
ROCK (18), leading to GLUT4 translocation towards the cell surface
and an increase in the glucose uptake into cells (Fig. 5). ROCK in-
cludes two isoforms ROCK1 and ROCK2. ROCK1 phosphorylates and
inhibits coﬁlin bearing actin depolymerization, thereby promoting
Fig. 4. Insulin- and diDCP-LA-PE-induced GLUT4 translocation is suppressed by
knocking-down Rac1 or ROCK1. Differentiated 3T3-L1-GLUT4myc adipocytes,
transfected with siRNAs for Rac1 (A) or ROCK1(B), were treated with insulin
(100 nM) or diDCP-LA-PE (diDCP) (1 mM) for 20 min. In the graphs in the left panels,
each column represents the mean (±SEM) signal intensity for each protein
normalized by that for b-actin (n ¼ 4 independent experiments). P values, unpaired
t-test. In the graphs in the right panels, each column represents the mean (±SEM)
signal intensity for GLUT4 on the plasma membrane relative to that for whole cells
(n ¼ 4 independent experiments). P values, ANOVA followed by a Bonferroni
correction. NS, not signiﬁcant.
Fig. 5. Schematic regulatory pathways for insulin- and diDCP-LA-PE-induced GLUT4
translocation. Insulin- or diDCP-LA-PE promotes GLUT4 translocation towards the cell
surface through a PI3K/PDK1/Akt pathway and by activating PKCz. PI3K, alternatively,
activates the Rac1 GEF Tiam1, to activate Rac1. Activated Rac1, in turn, binds to and
activate the Rac1 effector Dbs, a RhoA GEF, activate RhoA. Activated RhoA activates the
RhoA effector ROCK, leading to GLUT4 translocation towards the cell surface.
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a positive-feedback loop in the IRS-1/PI3K/PDK1/Akt pathway
relevant to GLUT4 translocation by phosphorylating IRS-1 at
Ser632/635 to enhance recruitment of PI3K (12). Consequently,
ROCK may also be an essential target of diDCP-LA-PE as well as
insulin in the regulation of GLUT4 translocation.
In conclusion, the results of the present study demonstrate that
Rac1 and ROCK are implicated in the regulation of GLUT4 trans-
location induced by the phosphatidylethanolamine derivative
diDCP-LA-PE mimicking insulin signaling.Conﬂicts of interest
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